APO Research
Talk to an analyst

APO RESEARCH · REPORT

Metabotropic Glutamate Receptor 5

Compare research editions
View pricing & licenses

Selected research

Industry Research

Metabotropic Glutamate Receptor 5 Industry Research Report 2026

22 December 2025125 pages

Choose your research edition.

Industry ResearchMetabotropic Glutamate Receptor 5 Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Metabotropic Glutamate Receptor 5 Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Metabotropic Glutamate Receptor 5 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Metabotropic Glutamate Receptor 5 Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Metabotropic Glutamate Receptor 5 Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Metabotropic Glutamate Receptor 5 market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Metabotropic Glutamate Receptor 5 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Metabotropic Glutamate Receptor 5 is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Metabotropic Glutamate Receptor 5 is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Metabotropic Glutamate Receptor 5 include Addex Therapeutics Ltd, Aevi Genomic Medicine Inc, Bristol-Myers Squibb Company, Heptares Therapeutics Ltd, Merz Pharma GmbH & Co KgaA, Richter Gedeon Nyrt, Sumitomo Dainippon Pharma Co Ltd, Toray Industries Inc and Eli Lilly and Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Metabotropic Glutamate Receptor 5 market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Metabotropic Glutamate Receptor 5 Market by Company

Addex Therapeutics Ltd

Aevi Genomic Medicine Inc

Bristol-Myers Squibb Company

Heptares Therapeutics Ltd

Merz Pharma GmbH & Co KgaA

Richter Gedeon Nyrt

Sumitomo Dainippon Pharma Co Ltd

Toray Industries Inc

Eli Lilly and Company

Novartis AG

Johnson & Johnson

Eisai Co Ltd

Metabotropic Glutamate Receptor 5 Segment by Type

Alloswitch-1

BMS-952048

BMS-955829

Dipraglurant ER

Others

Metabotropic Glutamate Receptor 5 Segment by Application

Major Depressive Disorder

Alcohol Addiction

Alzheimer's Disease

Others

Metabotropic Glutamate Receptor 5 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metabotropic Glutamate Receptor 5 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Metabotropic Glutamate Receptor 5 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metabotropic Glutamate Receptor 5.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Metabotropic Glutamate Receptor 5 manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Metabotropic Glutamate Receptor 5 by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Metabotropic Glutamate Receptor 5 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Metabotropic Glutamate Receptor 5 Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Metabotropic Glutamate Receptor 5 Sales (k units) of Manufacturers (2021-2026) Table 7. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Manufacturers (2021-2026) Table 8. Global Metabotropic Glutamate Receptor 5 Revenue of Manufacturers (2021-2026) Table 9. Global Metabotropic Glutamate Receptor 5 Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Metabotropic Glutamate Receptor 5 Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Metabotropic Glutamate Receptor 5 Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Metabotropic Glutamate Receptor 5, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Metabotropic Glutamate Receptor 5, Product Type & Application Table 14. Global Metabotropic Glutamate Receptor 5 Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Metabotropic Glutamate Receptor 5 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Addex Therapeutics Ltd Company Information Table 19. Addex Therapeutics Ltd Business Overview Table 20. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Portfolio Table 22. Addex Therapeutics Ltd Recent Developments Table 23. Aevi Genomic Medicine Inc Company Information Table 24. Aevi Genomic Medicine Inc Business Overview Table 25. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Product Portfolio Table 27. Aevi Genomic Medicine Inc Recent Developments Table 28. Bristol-Myers Squibb Company Company Information Table 29. Bristol-Myers Squibb Company Business Overview Table 30. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Product Portfolio Table 32. Bristol-Myers Squibb Company Recent Developments Table 33. Heptares Therapeutics Ltd Company Information Table 34. Heptares Therapeutics Ltd Business Overview Table 35. Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Portfolio Table 37. Heptares Therapeutics Ltd Recent Developments Table 38. Merz Pharma GmbH & Co KgaA Company Information Table 39. Merz Pharma GmbH & Co KgaA Business Overview Table 40. Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Product Portfolio Table 42. Merz Pharma GmbH & Co KgaA Recent Developments Table 43. Richter Gedeon Nyrt Company Information Table 44. Richter Gedeon Nyrt Business Overview Table 45. Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Product Portfolio Table 47. Richter Gedeon Nyrt Recent Developments Table 48. Sumitomo Dainippon Pharma Co Ltd Company Information Table 49. Sumitomo Dainippon Pharma Co Ltd Business Overview Table 50. Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Product Portfolio Table 52. Sumitomo Dainippon Pharma Co Ltd Recent Developments Table 53. Toray Industries Inc Company Information Table 54. Toray Industries Inc Business Overview Table 55. Toray Industries Inc Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Toray Industries Inc Metabotropic Glutamate Receptor 5 Product Portfolio Table 57. Toray Industries Inc Recent Developments Table 58. Eli Lilly and Company Company Information Table 59. Eli Lilly and Company Business Overview Table 60. Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Eli Lilly and Company Metabotropic Glutamate Receptor 5 Product Portfolio Table 62. Eli Lilly and Company Recent Developments Table 63. Novartis AG Company Information Table 64. Novartis AG Business Overview Table 65. Novartis AG Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Novartis AG Metabotropic Glutamate Receptor 5 Product Portfolio Table 67. Novartis AG Recent Developments Table 68. Johnson & Johnson Company Information Table 69. Johnson & Johnson Business Overview Table 70. Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Johnson & Johnson Metabotropic Glutamate Receptor 5 Product Portfolio Table 72. Johnson & Johnson Recent Developments Table 73. Eisai Co Ltd Company Information Table 74. Eisai Co Ltd Business Overview Table 75. Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Eisai Co Ltd Metabotropic Glutamate Receptor 5 Product Portfolio Table 77. Eisai Co Ltd Recent Developments Table 78. Global Metabotropic Glutamate Receptor 5 Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 79. Global Metabotropic Glutamate Receptor 5 Sales by Region (2021-2026) & (k units) Table 80. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Region (2021-2026) Table 81. Global Metabotropic Glutamate Receptor 5 Sales by Region (2027-2032) & (k units) Table 82. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Region (2027-2032) Table 83. Global Metabotropic Glutamate Receptor 5 Revenue by Region (2021-2026) & (US$ Million) Table 84. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Region (2021-2026) Table 85. Global Metabotropic Glutamate Receptor 5 Revenue by Region (2027-2032) & (US$ Million) Table 86. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Region (2027-2032) Table 87. North America Metabotropic Glutamate Receptor 5 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. North America Metabotropic Glutamate Receptor 5 Sales by Country (2021-2026) & (k units) Table 89. North America Metabotropic Glutamate Receptor 5 Sales by Country (2027-2032) & (k units) Table 90. North America Metabotropic Glutamate Receptor 5 Revenue by Country (2021-2026) & (US$ Million) Table 91. North America Metabotropic Glutamate Receptor 5 Revenue by Country (2027-2032) & (US$ Million) Table 92. Europe Metabotropic Glutamate Receptor 5 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Europe Metabotropic Glutamate Receptor 5 Sales by Country (2021-2026) & (k units) Table 94. Europe Metabotropic Glutamate Receptor 5 Sales by Country (2027-2032) & (k units) Table 95. Europe Metabotropic Glutamate Receptor 5 Revenue by Country (2021-2026) & (US$ Million) Table 96. Europe Metabotropic Glutamate Receptor 5 Revenue by Country (2027-2032) & (US$ Million) Table 97. Asia Pacific Metabotropic Glutamate Receptor 5 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Asia Pacific Metabotropic Glutamate Receptor 5 Sales by Country (2021-2026) & (k units) Table 99. Asia Pacific Metabotropic Glutamate Receptor 5 Sales by Country (2027-2032) & (k units) Table 100. Asia Pacific Metabotropic Glutamate Receptor 5 Revenue by Country (2021-2026) & (US$ Million) Table 101. Asia Pacific Metabotropic Glutamate Receptor 5 Revenue by Country (2027-2032) & (US$ Million) Table 102. South America Metabotropic Glutamate Receptor 5 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. South America Metabotropic Glutamate Receptor 5 Sales by Country (2021-2026) & (k units) Table 104. South America Metabotropic Glutamate Receptor 5 Sales by Country (2027-2032) & (k units) Table 105. South America Metabotropic Glutamate Receptor 5 Revenue by Country (2021-2026) & (US$ Million) Table 106. South America Metabotropic Glutamate Receptor 5 Revenue by Country (2027-2032) & (US$ Million) Table 107. Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Country (2021-2026) & (k units) Table 109. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Country (2027-2032) & (k units) Table 110. Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue by Country (2021-2026) & (US$ Million) Table 111. Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue by Country (2027-2032) & (US$ Million) Table 112. Global Metabotropic Glutamate Receptor 5 Sales by Type (2021-2026) & (k units) Table 113. Global Metabotropic Glutamate Receptor 5 Sales by Type (2027-2032) & (k units) Table 114. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2021-2026) Table 115. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2027-2032) Table 116. Global Metabotropic Glutamate Receptor 5 Revenue by Type (2021-2026) & (US$ Million) Table 117. Global Metabotropic Glutamate Receptor 5 Revenue by Type (2027-2032) & (US$ Million) Table 118. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2021-2026) Table 119. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2027-2032) Table 120. Global Metabotropic Glutamate Receptor 5 Price by Type (2021-2026) & (US$/unit) Table 121. Global Metabotropic Glutamate Receptor 5 Price by Type (2027-2032) & (US$/unit) Table 122. Global Metabotropic Glutamate Receptor 5 Sales by Application (2021-2026) & (k units) Table 123. Global Metabotropic Glutamate Receptor 5 Sales by Application (2027-2032) & (k units) Table 124. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2021-2026) Table 125. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2027-2032) Table 126. Global Metabotropic Glutamate Receptor 5 Revenue by Application (2021-2026) & (US$ Million) Table 127. Global Metabotropic Glutamate Receptor 5 Revenue by Application (2027-2032) & (US$ Million) Table 128. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2021-2026) Table 129. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2027-2032) Table 130. Global Metabotropic Glutamate Receptor 5 Price by Application (2021-2026) & (US$/unit) Table 131. Global Metabotropic Glutamate Receptor 5 Price by Application (2027-2032) & (US$/unit) Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Metabotropic Glutamate Receptor 5 Distributors List Table 135. Metabotropic Glutamate Receptor 5 Customers List Table 136. Metabotropic Glutamate Receptor 5 Industry Trends Table 137. Metabotropic Glutamate Receptor 5 Industry Drivers Table 138. Metabotropic Glutamate Receptor 5 Industry Restraints Table 139. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Metabotropic Glutamate Receptor 5 Product Image Figure 5. Global Metabotropic Glutamate Receptor 5 Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Metabotropic Glutamate Receptor 5 Market Size (2021-2032) & (US$ Million) Figure 7. Global Metabotropic Glutamate Receptor 5 Sales (2021-2032) & (k units) Figure 8. Global Metabotropic Glutamate Receptor 5 Average Price (US$/unit) & (2021-2032) Figure 9. Alloswitch-1 Product Image Figure 10. BMS-952048 Product Image Figure 11. BMS-955829 Product Image Figure 12. Dipraglurant ER Product Image Figure 13. Others Product Image Figure 14. Major Depressive Disorder Product Image Figure 15. Alcohol Addiction Product Image Figure 16. Alzheimer's Disease Product Image Figure 17. Others Product Image Figure 18. Global Metabotropic Glutamate Receptor 5 Revenue Share by Manufacturers in 2025 Figure 19. Global Manufacturers of Metabotropic Glutamate Receptor 5, Manufacturing Sites & Headquarters Figure 20. Global Top 5 and 10 Metabotropic Glutamate Receptor 5 Players Market Share by Revenue in 2025 Figure 21. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Metabotropic Glutamate Receptor 5 Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 23. Global Metabotropic Glutamate Receptor 5 Sales by Region in 2025 Figure 24. Global Metabotropic Glutamate Receptor 5 Revenue by Region in 2025 Figure 25. North America Metabotropic Glutamate Receptor 5 Market Size by Country in 2025 Figure 26. North America Metabotropic Glutamate Receptor 5 Sales Market Share by Country (2021-2032) Figure 27. North America Metabotropic Glutamate Receptor 5 Revenue Market Share by Country (2021-2032) Figure 28. United States Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Canada Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Mexico Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Europe Metabotropic Glutamate Receptor 5 Market Size by Country in 2025 Figure 32. Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Country (2021-2032) Figure 33. Europe Metabotropic Glutamate Receptor 5 Revenue Market Share by Country (2021-2032) Figure 34. Germany Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. France Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. U.K. Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Italy Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Russia Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Spain Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Netherlands Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Switzerland Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Sweden Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Poland Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Asia Pacific Metabotropic Glutamate Receptor 5 Market Size by Country in 2025 Figure 45. Asia Pacific Metabotropic Glutamate Receptor 5 Sales Market Share by Country (2021-2032) Figure 46. Asia Pacific Metabotropic Glutamate Receptor 5 Revenue Market Share by Country (2021-2032) Figure 47. China Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Japan Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. South Korea Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. India Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Australia Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Taiwan Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Southeast Asia Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. South America Metabotropic Glutamate Receptor 5 Market Size by Country in 2025 Figure 56. South America Metabotropic Glutamate Receptor 5 Sales Market Share by Country (2021-2032) Figure 57. South America Metabotropic Glutamate Receptor 5 Revenue Market Share by Country (2021-2032) Figure 58. Brazil Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Argentina Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Chile Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Middle East and Africa Metabotropic Glutamate Receptor 5 Market Size by Country in 2025 Figure 62. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Market Share by Country (2021-2032) Figure 63. Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue Market Share by Country (2021-2032) Figure 64. Egypt Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. South Africa Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Israel Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Türkiye Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. GCC Countries Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2021-2032) Figure 70. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2021-2032) Figure 71. Global Metabotropic Glutamate Receptor 5 Price (US$/unit) by Type (2021-2032) Figure 72. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2021-2032) Figure 73. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2021-2032) Figure 74. Global Metabotropic Glutamate Receptor 5 Price (US$/unit) by Application (2021-2032) Figure 75. Metabotropic Glutamate Receptor 5 Value Chain Figure 76. Metabotropic Glutamate Receptor 5 Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Metabotropic Glutamate Receptor 5 Industry Opportunities and Challenges

Scope & coverage.

Types
  • Alloswitch-1
  • BMS-952048
  • BMS-955829
  • Dipraglurant ER
  • Others
Applications
  • Major Depressive Disorder
  • Alcohol Addiction
  • Alzheimer's Disease
  • Others
Companies covered
  • Addex Therapeutics Ltd
  • Aevi Genomic Medicine Inc
  • Bristol-Myers Squibb Company
  • Heptares Therapeutics Ltd
  • Merz Pharma GmbH & Co KgaA
  • Richter Gedeon Nyrt
  • Sumitomo Dainippon Pharma Co Ltd
  • Toray Industries Inc
  • Eli Lilly and Company
  • Novartis AG
  • Johnson & Johnson
  • Eisai Co Ltd

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Metabotropic Glutamate Receptor 5 Market Size (2021-2032)
  4. 2.2.2 Global Metabotropic Glutamate Receptor 5 Sales (2021-2032)
  5. 2.2.3 Global Metabotropic Glutamate Receptor 5 Market Average Price (2021-2032)
  6. 2.3 Metabotropic Glutamate Receptor 5 by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Alloswitch-1
  9. 2.3.3 BMS-952048
  10. 2.3.4 BMS-955829
  11. 2.3.5 Dipraglurant ER
  12. 2.3.6 Others
  13. 2.4 Metabotropic Glutamate Receptor 5 by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 Major Depressive Disorder
  16. 2.4.3 Alcohol Addiction
  17. 2.4.4 Alzheimer's Disease
  18. 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Metabotropic Glutamate Receptor 5 Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Metabotropic Glutamate Receptor 5 Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Metabotropic Glutamate Receptor 5 Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Metabotropic Glutamate Receptor 5 Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Metabotropic Glutamate Receptor 5 Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Metabotropic Glutamate Receptor 5, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Metabotropic Glutamate Receptor 5, Product Type & Application
  8. 3.8 Global Manufacturers of Metabotropic Glutamate Receptor 5, Established Date
  9. 3.9 Global Metabotropic Glutamate Receptor 5 Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Addex Therapeutics Ltd
  2. 4.1.1 Addex Therapeutics Ltd Company Information
  3. 4.1.2 Addex Therapeutics Ltd Business Overview
  4. 4.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Portfolio
  6. 4.1.5 Addex Therapeutics Ltd Recent Developments
  7. 4.2 Aevi Genomic Medicine Inc
  8. 4.2.1 Aevi Genomic Medicine Inc Company Information
  9. 4.2.2 Aevi Genomic Medicine Inc Business Overview
  10. 4.2.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Product Portfolio
  12. 4.2.5 Aevi Genomic Medicine Inc Recent Developments
  13. 4.3 Bristol-Myers Squibb Company
  14. 4.3.1 Bristol-Myers Squibb Company Company Information
  15. 4.3.2 Bristol-Myers Squibb Company Business Overview
  16. 4.3.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Product Portfolio
  18. 4.3.5 Bristol-Myers Squibb Company Recent Developments
  19. 4.4 Heptares Therapeutics Ltd
  20. 4.4.1 Heptares Therapeutics Ltd Company Information
  21. 4.4.2 Heptares Therapeutics Ltd Business Overview
  22. 4.4.3 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Portfolio
  24. 4.4.5 Heptares Therapeutics Ltd Recent Developments
  25. 4.5 Merz Pharma GmbH & Co KgaA
  26. 4.5.1 Merz Pharma GmbH & Co KgaA Company Information
  27. 4.5.2 Merz Pharma GmbH & Co KgaA Business Overview
  28. 4.5.3 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Product Portfolio
  30. 4.5.5 Merz Pharma GmbH & Co KgaA Recent Developments
  31. 4.6 Richter Gedeon Nyrt
  32. 4.6.1 Richter Gedeon Nyrt Company Information
  33. 4.6.2 Richter Gedeon Nyrt Business Overview
  34. 4.6.3 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Product Portfolio
  36. 4.6.5 Richter Gedeon Nyrt Recent Developments
  37. 4.7 Sumitomo Dainippon Pharma Co Ltd
  38. 4.7.1 Sumitomo Dainippon Pharma Co Ltd Company Information
  39. 4.7.2 Sumitomo Dainippon Pharma Co Ltd Business Overview
  40. 4.7.3 Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Product Portfolio
  42. 4.7.5 Sumitomo Dainippon Pharma Co Ltd Recent Developments
  43. 4.8 Toray Industries Inc
  44. 4.8.1 Toray Industries Inc Company Information
  45. 4.8.2 Toray Industries Inc Business Overview
  46. 4.8.3 Toray Industries Inc Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Toray Industries Inc Metabotropic Glutamate Receptor 5 Product Portfolio
  48. 4.8.5 Toray Industries Inc Recent Developments
  49. 4.9 Eli Lilly and Company
  50. 4.9.1 Eli Lilly and Company Company Information
  51. 4.9.2 Eli Lilly and Company Business Overview
  52. 4.9.3 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Product Portfolio
  54. 4.9.5 Eli Lilly and Company Recent Developments
  55. 4.10 Novartis AG
  56. 4.10.1 Novartis AG Company Information
  57. 4.10.2 Novartis AG Business Overview
  58. 4.10.3 Novartis AG Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Novartis AG Metabotropic Glutamate Receptor 5 Product Portfolio
  60. 4.10.5 Novartis AG Recent Developments
  61. 4.11 Johnson & Johnson
  62. 4.11.1 Johnson & Johnson Company Information
  63. 4.11.2 Johnson & Johnson Business Overview
  64. 4.11.3 Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Johnson & Johnson Metabotropic Glutamate Receptor 5 Product Portfolio
  66. 4.11.5 Johnson & Johnson Recent Developments
  67. 4.12 Eisai Co Ltd
  68. 4.12.1 Eisai Co Ltd Company Information
  69. 4.12.2 Eisai Co Ltd Business Overview
  70. 4.12.3 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Product Portfolio
  72. 4.12.5 Eisai Co Ltd Recent Developments
5 Global Metabotropic Glutamate Receptor 5 Market Scenario by Region
  1. 5.1 Global Metabotropic Glutamate Receptor 5 Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Metabotropic Glutamate Receptor 5 Sales by Region: 2021-2032
  3. 5.2.1 Global Metabotropic Glutamate Receptor 5 Sales by Region: 2021-2026
  4. 5.2.2 Global Metabotropic Glutamate Receptor 5 Sales by Region: 2027-2032
  5. 5.3 Global Metabotropic Glutamate Receptor 5 Revenue by Region: 2021-2032
  6. 5.3.1 Global Metabotropic Glutamate Receptor 5 Revenue by Region: 2021-2026
  7. 5.3.2 Global Metabotropic Glutamate Receptor 5 Revenue by Region: 2027-2032
  8. 5.4 North America Metabotropic Glutamate Receptor 5 Market Facts & Figures by Country
  9. 5.4.1 North America Metabotropic Glutamate Receptor 5 Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Metabotropic Glutamate Receptor 5 Sales by Country (2021-2032)
  11. 5.4.3 North America Metabotropic Glutamate Receptor 5 Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Metabotropic Glutamate Receptor 5 Market Facts & Figures by Country
  16. 5.5.1 Europe Metabotropic Glutamate Receptor 5 Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Metabotropic Glutamate Receptor 5 Sales by Country (2021-2032)
  18. 5.5.3 Europe Metabotropic Glutamate Receptor 5 Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Metabotropic Glutamate Receptor 5 Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Metabotropic Glutamate Receptor 5 Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Metabotropic Glutamate Receptor 5 Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Metabotropic Glutamate Receptor 5 Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Metabotropic Glutamate Receptor 5 Market Facts & Figures by Country
  41. 5.7.1 South America Metabotropic Glutamate Receptor 5 Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Metabotropic Glutamate Receptor 5 Sales by Country (2021-2032)
  43. 5.7.3 South America Metabotropic Glutamate Receptor 5 Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Metabotropic Glutamate Receptor 5 Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Metabotropic Glutamate Receptor 5 Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Metabotropic Glutamate Receptor 5 Sales by Type (2021-2032)
  2. 6.1.1 Global Metabotropic Glutamate Receptor 5 Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2021-2032)
  4. 6.2 Global Metabotropic Glutamate Receptor 5 Revenue by Type (2021-2032)
  5. 6.2.1 Global Metabotropic Glutamate Receptor 5 Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Metabotropic Glutamate Receptor 5 Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Metabotropic Glutamate Receptor 5 Sales by Application (2021-2032)
  2. 7.1.1 Global Metabotropic Glutamate Receptor 5 Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2021-2032)
  4. 7.2 Global Metabotropic Glutamate Receptor 5 Revenue by Application (2021-2032)
  5. 7.2.1 Global Metabotropic Glutamate Receptor 5 Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Metabotropic Glutamate Receptor 5 Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Metabotropic Glutamate Receptor 5 Value Chain Analysis
  2. 8.1.1 Metabotropic Glutamate Receptor 5 Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Metabotropic Glutamate Receptor 5 Production Mode & Process
  5. 8.2 Metabotropic Glutamate Receptor 5 Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Metabotropic Glutamate Receptor 5 Distributors
  8. 8.2.3 Metabotropic Glutamate Receptor 5 Customers
9 Global Metabotropic Glutamate Receptor 5 Analyzing Market Dynamics
  1. 9.1 Metabotropic Glutamate Receptor 5 Industry Trends
  2. 9.2 Metabotropic Glutamate Receptor 5 Industry Drivers
  3. 9.3 Metabotropic Glutamate Receptor 5 Industry Opportunities and Challenges
  4. 9.4 Metabotropic Glutamate Receptor 5 Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst